The emerging treatment of the medication represents a major development in the management of type 2 diabetes. Different to existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide523515.dm-blog.com/42427992/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment